In Vivo is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Cialis Prolonged Activity Widens Nitrate Concern; Risk Management Requested

This article was originally published in Pharmaceutical Approvals Monthly

Executive Summary

Cialis’ distinguishing feature – its longer window for efficacy than competing erectile dysfunction agents – also triggered concerns about a longer window for safety problems with the Lilly/Icos drug, FDA review documents indicate.
Advertisement

Related Content

Cialis Alcohol Interaction Among Key Factors Preventing First-Cycle Approval
Cialis Back Pain May Be Due To Greater PDE11 Affinity Than Viagra, Levitra
Lilly/Icos Cialis Development Strategy: FDA Delays Phase IIIs – Go Overseas
Lilly/Icos Cialis Development Strategy: FDA Delays Phase IIIs – Go Overseas
Lilly/Icos Cialis Development Strategy: FDA Delays Phase IIIs – Go Overseas
Cialis Alcohol Interaction Among Key Factors Preventing First-Cycle Approval
Cialis Back Pain May Be Due To Greater PDE11 Affinity Than Viagra, Levitra

Topics

Advertisement
UsernamePublicRestriction

Register

PS002515

Ask The Analyst

Ask the Analyst is free for subscribers.  Submit your question and one of our analysts will be in touch.

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel